Why is Kailera Therapeutics, Inc. stock down today?
June 23, 2026
Kailera Therapeutics, Inc.
KLRA · NMS · USD
vs. prev. close $22.88
Last updated Jun 23, 2026 15:13
Intraday Chart — 5-min intervals
KLRA · less than a minute ago
Kailera Therapeutics, Inc. slides 3.98% amid market weakness
Kailera Therapeutics, Inc. (KLRA) is selling off, at $21. 97 — down 3. 98% from yesterday's close of $22. 88. Today's move appears driven by recent headlines, including "Kardigan rises in Nasdaq debut after upsized $400 million IPO" and "3 Under-the-Radar Stocks to Buy and Hold for a Decade". News sentiment around KLRA is leaning positive.
The broader market is under pressure (S&P 500: -1. 1%, Nasdaq: -1. 7%, Dow Jones: +0. 0%, Shanghai: +1. 8%, Hang Seng: -1. 8%). Past performance does not guarantee future results.
Key Factors
Auto-generated analysis · Not financial advice
Kardigan rises in Nasdaq debut after upsized $400 million IPO
Reuters·5 days agopositive3 Under-the-Radar Stocks to Buy and Hold for a Decade
Motley Fool·7 days agoneutral‘I worry deeply about bioterrorism’: Is Europe sufficiently prepared for another pandemic?
Euronews·8 days agoneutralParabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too Late to Buy the Stock?
Motley Fool·11 days agopositiveHow to Play PBLS Stock After the Parabilis IPO
Barchart·12 days agoneutralParabilis sets a record with a $670M biotech IPO
BioPharma Dive·13 days agoneutralHengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
GlobeNewswire·18 days agoneutralKailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
GlobeNewswire·26 days agoneutral
S&P 500
-1.13%
Nasdaq
-1.73%
Dow Jones
+0.01%
Shanghai
+1.78%
Hang Seng
-1.82%
Nikkei 225
-3.55%
FTSE 100
+0.19%
Nifty 50
-1.16%
DAX
-0.74%
OMX Stockholm
-0.82%
Search another stock